- Home
- Publications
- Publication Search
- Publication Details
Title
Expression and prognostic value of the WEE1 kinase in gliomas
Authors
Keywords
Glioma, Glioblastoma, Prognosis, WEE1, Biomarker, Immunohistochemistry
Journal
JOURNAL OF NEURO-ONCOLOGY
Volume 127, Issue 2, Pages 381-389
Publisher
Springer Nature
Online
2016-01-07
DOI
10.1007/s11060-015-2050-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Integrated genomic analysis identifies the mitotic checkpoint kinase WEE1 as a novel therapeutic target in medulloblastoma
- (2014) Peter S Harris et al. Molecular Cancer
- TERT promoter mutations: a novel independent prognostic factor in primary glioblastomas
- (2014) Matthias Simon et al. NEURO-ONCOLOGY
- High-Throughput Flow Cytometry Screening Reveals a Role for Junctional Adhesion Molecule A as a Cancer Stem Cell Maintenance Factor
- (2014) Justin D. Lathia et al. Cell Reports
- A population-based study of low-grade gliomas and mutated isocitrate dehydrogenase 1 (IDH1)
- (2013) Rikke H. Dahlrot et al. JOURNAL OF NEURO-ONCOLOGY
- Prognostic value of Musashi-1 in gliomas
- (2013) Rikke H. Dahlrot et al. JOURNAL OF NEURO-ONCOLOGY
- Preclinical Evaluation of the WEE1 Inhibitor MK-1775 as Single-Agent Anticancer Therapy
- (2013) A. D. Guertin et al. MOLECULAR CANCER THERAPEUTICS
- Targeting Wee1 for the treatment of pediatric high-grade gliomas
- (2013) Sabine Mueller et al. NEURO-ONCOLOGY
- Hypoxia induces Wee1 expression and attenuates hydrogen peroxide-induced endothelial damage in MS1 cells
- (2012) Ki-Sun Hong et al. EXPERIMENTAL AND MOLECULAR MEDICINE
- MiR-21 expression in the tumor cell compartment holds unfavorable prognostic value in gliomas
- (2012) Simon Kjær Hermansen et al. JOURNAL OF NEURO-ONCOLOGY
- WEE1 inhibition sensitizes osteosarcoma to radiotherapy
- (2011) Jantine PosthumaDeBoer et al. BMC CANCER
- WEE1 Kinase Targeting Combined with DNA-Damaging Cancer Therapy Catalyzes Mitotic Catastrophe
- (2011) P. C. De Witt Hamer et al. CLINICAL CANCER RESEARCH
- MK1775, a Selective Wee1 Inhibitor, Shows Single-Agent Antitumor Activity against Sarcoma Cells
- (2011) J. M. Kreahling et al. MOLECULAR CANCER THERAPEUTICS
- Targeting Radiation-Induced G2 Checkpoint Activation with the Wee-1 Inhibitor MK-1775 in Glioblastoma Cell Lines
- (2011) B. Sarcar et al. MOLECULAR CANCER THERAPEUTICS
- Understanding Glioblastoma Tumor Biology: The Potential to Improve Current Diagnosis and Treatments
- (2011) Santosh Kesari SEMINARS IN ONCOLOGY
- In Silico Analysis of Kinase Expression Identifies WEE1 as a Gatekeeper against Mitotic Catastrophe in Glioblastoma
- (2010) Shahryar E. Mir et al. CANCER CELL
- Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
- (2009) Roger Stupp et al. LANCET ONCOLOGY
- Integrated Functional, Gene Expression and Genomic Analysis for the Identification of Cancer Targets
- (2009) Elizabeth Iorns et al. PLoS One
- Explorative data analysis of MCL reveals gene expression networks implicated in survival and prognosis supported by explorative CGH analysis
- (2008) Steffen Blenk et al. BMC CANCER
- Malignant Gliomas in Adults
- (2008) Patrick Y. Wen et al. NEW ENGLAND JOURNAL OF MEDICINE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started